DE3466396D1 - A retro-inverso analogue of the (5-14) decapeptide of equine angiotensinogen, as a specific renin inhibitor with high resistance to enzymatic hydrolysis - Google Patents

A retro-inverso analogue of the (5-14) decapeptide of equine angiotensinogen, as a specific renin inhibitor with high resistance to enzymatic hydrolysis

Info

Publication number
DE3466396D1
DE3466396D1 DE8484200710T DE3466396T DE3466396D1 DE 3466396 D1 DE3466396 D1 DE 3466396D1 DE 8484200710 T DE8484200710 T DE 8484200710T DE 3466396 T DE3466396 T DE 3466396T DE 3466396 D1 DE3466396 D1 DE 3466396D1
Authority
DE
Germany
Prior art keywords
retro
angiotensinogen
decapeptide
equine
high resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484200710T
Other languages
English (en)
Inventor
Massimo Pinori
Antonio Silvio Verdini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eni SpA
Original Assignee
Eni SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eni SpA filed Critical Eni SpA
Application granted granted Critical
Publication of DE3466396D1 publication Critical patent/DE3466396D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0212—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/32—Modification to prevent enzymatic degradation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
DE8484200710T 1983-05-25 1984-05-17 A retro-inverso analogue of the (5-14) decapeptide of equine angiotensinogen, as a specific renin inhibitor with high resistance to enzymatic hydrolysis Expired DE3466396D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21281/83A IT1164239B (it) 1983-05-25 1983-05-25 Un retro-inverso analogo del decapeptide (5-14)dell'angiotensinogeno equino inibitore specifico della renina con elevata resistenza all'idrolisi enzimatica

Publications (1)

Publication Number Publication Date
DE3466396D1 true DE3466396D1 (en) 1987-10-29

Family

ID=11179480

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484200710T Expired DE3466396D1 (en) 1983-05-25 1984-05-17 A retro-inverso analogue of the (5-14) decapeptide of equine angiotensinogen, as a specific renin inhibitor with high resistance to enzymatic hydrolysis

Country Status (8)

Country Link
US (1) US4560505A (de)
EP (1) EP0127234B1 (de)
JP (1) JPH0672153B2 (de)
AT (1) ATE29890T1 (de)
AU (1) AU558572B2 (de)
CA (1) CA1249699A (de)
DE (1) DE3466396D1 (de)
IT (1) IT1164239B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190389B (it) * 1985-09-19 1988-02-16 Eniricerche Spa Esapeptidi ad attivita' ipotensiva
ES2052517T3 (es) * 1986-07-16 1994-07-16 Eniricerche Spa Analogos de tuftsina parcialmente retroinversos, metodo de preparacion de los mismos y composiciones farmaceuticas que los contienen.
ATE107658T1 (de) * 1988-01-26 1994-07-15 Sankyo Co Renin inhibierende polypeptide, ihre herstellung und anwendung.
US5807979A (en) * 1988-04-08 1998-09-15 The Scripps Research Institute Synthetic, three-dimensionally stabilized polypeptide mimics of HIV
AU3534989A (en) * 1988-04-08 1989-11-03 Scripps Clinic And Research Foundation Polypeptides stabilized by covalent hydrogen bond replacements
DE4004820A1 (de) * 1989-08-05 1991-04-25 Bayer Ag Renininhibitoren, verfahren zur herstellung und ihre verwendung in arzneimitteln
US5242903A (en) * 1989-08-05 1993-09-07 Bayer Aktiengesellschaft Renin inhibitors
US6458357B1 (en) 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides
CA2520257A1 (en) * 2003-03-24 2004-10-07 Sequoia Pharmaceuticals, Inc. Long acting biologically active conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269827A (en) * 1980-06-23 1981-05-26 The Massachusetts General Hospital Process and composition for reducing blood pressure
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
JPS5759846A (en) * 1980-08-06 1982-04-10 Ferring Pharma Ltd Polypeptide homologue and manufacture of hydroxy or keto homologue of dipeptide
IT1212508B (it) * 1981-12-22 1989-11-22 Anic Spa Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
IT1190891B (it) * 1982-06-24 1988-02-24 Anic Spa Metodo per la sintesi in fase solida di polipeptidi retroinvertiti

Also Published As

Publication number Publication date
IT8321281A1 (it) 1984-11-25
US4560505A (en) 1985-12-24
AU558572B2 (en) 1987-02-05
EP0127234B1 (de) 1987-09-23
JPS59231055A (ja) 1984-12-25
EP0127234A3 (en) 1985-09-04
IT1164239B (it) 1987-04-08
CA1249699A (en) 1989-01-31
ATE29890T1 (de) 1987-10-15
JPH0672153B2 (ja) 1994-09-14
EP0127234A2 (de) 1984-12-05
AU2855384A (en) 1984-11-29
IT8321281A0 (it) 1983-05-25

Similar Documents

Publication Publication Date Title
DE3463442D1 (en) Arched bridge staple
DE3478928D1 (en) Enzyme inhibition
NZ209589A (en) Method of extracting human immune interferon from transformed microorganisms in the precence of a protease inhibitor
MY100641A (en) Neutral metalloendopeptidase inhibitors in the treatment of hypertension.
FI922434A (fi) Produktion av rekombinant human interleukin-1-inhibitor.
DE3466396D1 (en) A retro-inverso analogue of the (5-14) decapeptide of equine angiotensinogen, as a specific renin inhibitor with high resistance to enzymatic hydrolysis
AU3951589A (en) Peptide derivatives containing proline and leucine for use in affinity chromatography and a process for the preparation thereof
NZ215096A (en) Renin inhibiting peptide derivatives, pepstatin analogues
EP0736033A4 (de) Neue therapeutische kohlenhydratmischungen zur verwendung bei prämenstruellem syndrom
IT1164240B (it) Decapeptide parzialmente retro-invertito inibitore specifico della renina con elevata resistenza alla idrolisi enzimatica
DE3261206D1 (en) Bis-thymosine alpha-1 compounds
WO1991019734A3 (en) Thrombin inhibitors based on the amino acid sequence of hirudin
ES2084635T3 (es) Derivados peptidicos utiles como antagonistas de la bombesina y del peptido que libera la gastrina.
DE3569541D1 (en) Pharmacologically active peptides
DK146890A (da) Mercapto-acylaminosyre-antihypertensiva
ES8302433A1 (es) "procedimiento de preparar agentes edulcorantes".
SE0002041D0 (sv) Gel spot picker
AU7470681A (en) Glicentin related purified peptide having 30 amino acids
ES8607988A1 (es) Procedimiento para la obtencion del maleato de 1-(n-(1(s)- (etoxicarbonil)-3-fenilpropil)-l-alanil)-l-prolina
UA32150A (uk) Спосіб лікування виразкової хвороби гастродуоденальної локалізації
RU96102431A (ru) Способ лечения псориаза
GB2300188A (en) Metalloproteinase inhibitors
UA16958A1 (uk) Ультразвуковий перетворювач
AU117609S (en) Tool
RU98118763A (ru) Способ лечения первичной артериальной гипертензии

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee